Acceptance rate:
Time to first decision with review:
42 days*
Time from acceptance to publication:
22 days*
Impact Factor(JCR):
Total content views:
2.21 million

Aims and scope

Journal of Neurology, Neurosurgery & Psychiatry (JNNP)’s ambition is to publish the most ground-breaking and cutting-edge research from around the world. Encompassing the entire genre of neurological sciences, our focus is on the common disorders (stroke, multiple sclerosis, Parkinson’s disease, epilepsy, peripheral neuropathy, subarachnoid haemorrhage and neuropsychiatry), but with a keen interest in the Gordian knots that present themselves in the field, such as ALS. With early online publication, regular podcasts and an immense archive collection (with the longest half-life of any journal in clinical neuroscience), JNNP is a trail-blazer and not a follower. Subscribers to JNNP also have access to Practical Neurology and the Journal of NeuroInterventional Surgery. JNNP is the flagship of BMJ’s neurology and neuroscience portfolio and has an open access companion journal, BMJ Neurology Open. For information about the Editor-in-Chief and editorial team, please refer to the Editorial Board page.

Plan S compliance

Journal of Neurology, Neurosurgery & Psychiatry is a Plan S compliant Transformative Journal. Transformative Journals are one of the compliance routes offered by cOAlition S funders, such as Wellcome, WHO and UKRI. Find out more about Transformative Journals and Plan S compliance on our Author Hub.


Practical Neurology Practical Neurology is a bi-monthly educational supplement, free to JNNP subscribers. Each issue of Practical Neurology publishes reviews and essays from eminent neurologists from around the world, as well as educational material to test your knowledge. Papers are rigorously edited to present the working neurologist with accessible, engaging, up-to-date information.

Journal information

JNNP is owned by BMJ
Publication Model
Subscription; with hybrid open access option
12 issues per year
Launch date
Digital Archives
Indexed by
Web of Science Core Collection: Science Citation Index, Science Citation Index Extended; BIOSIS Previews, Current Contents: Clinical Medicine, Life Sciences, MEDLINE (Index Medicus), PubMed Central (BMJ Open Access Special Collection), Scopus, Embase (Excerpta Medica), CINAHL, Google Scholar
Peer Review Model
Single anonymised; the names of reviewers are hidden from the author
Print ISSN
Online ISSN

Journal Statistics 2023

Acceptance rate: 9%
Speed Time to first decision with review: 42 days (median) Time to first decision without review: 4 days (median) Time from acceptance to publication: 22 days (median)
Impact Impact Factor category: Clinical Neurology Impact factor (JCR): 11.1 Impact Factor rank: 10/212 5 year Impact Factor: 10.7 Journal Citation Indicator (JCI): 2.77 Eigenfactor Score: 0.02554 Citescore: 15.9 Citescore rank: 11/373 Scimago Journal rank (SJR): 3.178
Reach Total content views: 2.21 million Total Altmetric mentions: 10,618
Dora logo
The impact that academic research has cannot be defined by one single metric. In 2013, BMJ signed the San Francisco Declaration on Research Assessment (DORA). We did this to show our support for using multiple measures and metrics to portray journals’ impact; moving away from the Impact Factor as a single measure. How we get these metrics

Contact information

For all contact information please refer to the Contact Us page.

For authors

Please refer to the Instructions for Authors


COPE logo
The BMJ Publishing Group is a founding member of COPE (the Committee on Publication Ethics), which provides a forum for publishers and Editors of scientific journals to discuss issues relating to the integrity of the work submitted to or published in their journals.
Equator Network logo
The EQUATOR Network is an international initiative that seeks to improve the value of medical research literature by promoting accurate, transparent reporting of research studies. The BMJ Group is a sponsor of its activities.
AllTrials logo
BMJ is a founding organisation of the AllTrials initiative, which calls for all past and present clinical trials to be registered and their results reported.